Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters

Therapeutic Methods and Therapies TCIM
Database
Type of study
Language
Affiliation country
Publication year range
1.
Bratisl Lek Listy ; 116(2): 128-31, 2015.
Article in English | MEDLINE | ID: mdl-25665481

ABSTRACT

BACKGROUND: This experimental study compared the hemostatic effects of calcium alginate and Anka-ferd Blood Stopper in hepatic parenchymal bleedings. MATERIAL AND METHOD: The study comprised 39 male Wistar albino rats (weight 230±30 g). Laceration model was created in the left lateral lobe of the liver. Standard cotton gauze that was impregnated 0.9% NaCl solution and Calcium alginate cover was compared to ABS tampon. The amount of preoperative bleeding, preoperative and postoperative Day 1 hematocrit levels, and the difference between them were assessed and statistically analyzed. RESULTS: Comparing the hematocrit levels between the groups, we found that the amount of bleeding was significantly higher in the control group versus the study groups (p<0.001). Histopathological examination revealed the portal area enlargement and biliary canaliculi proliferation. In the Ca2+ Alginate group, it was observed that the fibres were still present in the incision line with massive fibrotic area around. In the Ankaferd group, examination of the preparations revealed patchy focal necrosis areas but no fibrotic area. CONCLUSION: With this study, we demonstrated that both calcium alginate and Ankaferd have hemostatic effect in preventing hepatic parenchymal bleeding and that calcium alginate causes fibrosis in the liver, where ABS causes focal necrosis areas(Tab. 2, Fig. 4, Ref. 19).


Subject(s)
Alginates/pharmacology , Gastrointestinal Hemorrhage/prevention & control , Hemostatics/pharmacology , Liver/injuries , Plant Extracts/pharmacology , Animals , Bleeding Time , Blood Loss, Surgical/prevention & control , Disease Models, Animal , Gastrointestinal Hemorrhage/drug therapy , Glucuronic Acid/pharmacology , Hemostasis/drug effects , Hemostatics/administration & dosage , Hexuronic Acids/pharmacology , Male , Rats , Rats, Wistar
2.
Bratisl Lek Listy ; 115(9): 544-9, 2014.
Article in English | MEDLINE | ID: mdl-25318912

ABSTRACT

AIM: The present study aimed to evaluate intra-abdominal adhesion generating potential of Ankaferd Blood Stopper (ABS), which was used as postoperative hemostatic agent in the rats that underwent surgery, in comparison with Ca-alginate. MATERIAL AND METHOD: Totally, 30 rats were randomized into 4 groups. In the control group, 1x1 cm peritoneum was removed from the right lower quadrant after cecal abrasion. In the other two study groups, the same procedure was performed after Ankaferd Blood Stopper and Ca-alginate application respectively. RESULTS were evaluated both histopathologically and by adhesion scoring methods. All results underwent statistical analysis. RESULTS: Comparing overall results, no statistically significant difference was found between the sham, control, ABS and Ca-alginate groups (p = 0.099). Paired group comparisons revealed no statistically significant difference between the sham group and the control, ABS, and Ca-alginate groups (p = 0.222, p = 0.222, and p = 0.833 respectively). It was observed that there was no statistically significant difference between the control and ABS groups (p = 0.505), but there was a statistically significant difference between the control and Ca-alginate groups with Bonferroni correction (p = 0.028). Histopathological examination revealed no statistical difference between the groups. CONCLUSION: In conclusion, intra-abdominal adhesion generating potentials of Ca-alginate and ABS were experimentally evaluated and macroscopic and microscopic comparisons revealed no significant difference between sham, control, Ca-alginate, and ABS groups (Fig. 8, Ref. 36). Text in PDF www.elis.sk. agent.


Subject(s)
Abdominal Cavity , Alginates/therapeutic use , Cecal Diseases/etiology , Hemostatics/therapeutic use , Plant Extracts/therapeutic use , Postoperative Hemorrhage/prevention & control , Animals , Cecal Diseases/pathology , Female , Glucuronic Acid/therapeutic use , Hexuronic Acids/therapeutic use , Laparotomy/adverse effects , Postoperative Hemorrhage/etiology , Rats , Rats, Wistar , Tissue Adhesions/etiology
3.
Eur Surg Res ; 41(2): 231-7, 2008.
Article in English | MEDLINE | ID: mdl-18525208

ABSTRACT

BACKGROUND: Propolis is a natural product collected by honey bees from various plant sources. We aimed to determine the possible effects of propolis on oxidative stress and hepatocyte apoptosis in experimental obstructive jaundice. METHODS: Thirty rats were divided into three groups: group I, sham-operated; group II, ligation and division of the common bile duct (BDL); group III, BDL followed by oral supplementation of propolis in a daily dose of 100 mg/kg. Liver samples were examined under the light microscope and transmission electron microscope. Hepatocyte apoptosis was quantitated using the transferase-mediated uridine nick end labeling (TUNEL) assay. Plasma and liver malondialdehyde (MDA) levels and glutathione peroxidase (GSH-Px) activities were measured. RESULTS: The plasma and liver levels of MDA were significantly lower in the propolis group than in the BDL group (p < 0.05 and 0.014, respectively). Although liver GSH-Px activities were significantly higher in the propolis group than in the BDL group (p < 0.001), there was no significant difference between the plasma GSH-Px activities of these groups (p > 0.05). In the propolis group, the enlargement of hepatocytes, dilatation of canaliculi and the edema regressed. The regenerating and normal hepatocytes were demonstrated. In the TUNEL assay, propolis administration reduced hepatocyte apoptosis. CONCLUSION: Propolis showed a significant hepatoprotective effect in this experimental obstructive jaundice model.


Subject(s)
Anti-Infective Agents/pharmacology , Jaundice, Obstructive , Oxidative Stress/drug effects , Propolis/pharmacology , Animals , Apoptosis/drug effects , Disease Models, Animal , Glutathione Peroxidase/metabolism , Hepatocytes/drug effects , Hepatocytes/pathology , Hepatocytes/ultrastructure , In Situ Nick-End Labeling , Jaundice, Obstructive/drug therapy , Jaundice, Obstructive/metabolism , Jaundice, Obstructive/pathology , Kupffer Cells/drug effects , Kupffer Cells/pathology , Kupffer Cells/ultrastructure , Male , Malondialdehyde/metabolism , Microscopy, Electron , Rats , Rats, Wistar
SELECTION OF CITATIONS
SEARCH DETAIL